|
Video: What is a Stock Split?
|
|
SIGA Technologies is a commercial-stage pharmaceutical company. Co. sells its primary product, TPOXX® (oral TPOXX®), to the U.S. government and international governments (including government affiliated entities). Additionally, Co. sells the intravenous formulation of TPOXX® to the U.S. Government. TPOXX® is an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. Co. has been delivering oral TPOXX® to the U.S. Strategic National Stockpile. According to our SIGA split history records, SIGA Technologies has had 0 splits. | |
|
SIGA Technologies (SIGA) has 0 splits in our SIGA split history database.
Looking at the SIGA split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into SIGA Technologies shares, starting with a $10,000 purchase of SIGA, presented on a split-history-adjusted basis factoring in the complete SIGA split history.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$2.82 |
|
End price/share: |
$8.64 |
|
Starting shares: |
3,546.10 |
|
Ending shares: |
4,346.23 |
|
Dividends reinvested/share: |
$1.50 |
|
Total return: |
275.51% |
|
Average Annual Total Return: |
14.15% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$37,549.29 |
|
Years: |
10.00 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$2.82 |
|
End price/share: |
$8.64 |
|
Dividends collected/share: |
$1.50 |
|
Total return: |
259.57% |
|
Average Annual Total Return: |
13.66% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$35,968.65 |
|
Years: |
10.00 |
|
|
|
|
|